todeposit218378659-1-
Guru 3D / Shutterstock.com
4 November 2014PharmaPeter ten Haaft

Patent protection for microorganisms

Disclosure of the invention is a requirement for a patent application. A person skilled in the art should be able to perform the invention without undue burden based on the description of the invention in the application. In general, the requirements of disclosure are met by a written description that enables the person skilled in the art to perform a claimed method or to obtain a claimed product. Where a microorganism is involved, a written description may be sufficient to perform a claimed method or to obtain a claimed (biological) product.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Pharma
11 August 2026   A litigation campaign against generic drugmakers, including Sandoz, Hikma, and Amenal, raise the stakes in the fight over two of the world’s most lucrative weight loss and diabetes treatments.
Pharma
10 August 2026   Takanori Abe of Abe & Partners brings the perspective of a lawyer with first-hand experience in the German courtrooms to Pharmaceutical, Biological and Chemical Patents, a valuable resource on case law.
Pharma
6 August 2026   A Netherlands court ruling marks the latest win as Novo Nordisk ramps up efforts to protect semaglutide from unapproved products, copycats and an increasingly competitive market.